Journal article
Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease
Abstract
BACKGROUND: The combination of 2.5 mg rivaroxaban twice daily and 100 mg aspirin once daily compared with 100 mg aspirin once daily reduces major adverse cardiovascular (CV) events in patients with chronic coronary artery disease (CAD) or peripheral artery disease (PAD).
OBJECTIVES: The aim of this work was to report the effects of the combination on overall and cause-specific mortality.
Authors
Eikelboom JW; Bhatt DL; Fox KAA; Bosch J; Connolly SJ; Anand SS; Avezum A; Berkowitz SD; Branch KRH; Dagenais GR
Journal
Journal of the American College of Cardiology, Vol. 78, No. 1, pp. 14–23
Publisher
Elsevier
Publication Date
July 2021
DOI
10.1016/j.jacc.2021.04.083
ISSN
0735-1097